BioLingus (Cayman) Limited (SUBL)

BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.

IPO Price

$20.00

Shares Offered

360,000

Deal Size

$7.20M

SUBL Financials Overview

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Oct '22 Oct 31, 2022	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Operating Income	-0.62	-1.37	-1.91
Net Income	-0.58	-1.42	-2.03

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Oct '22 Oct 31, 2022	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Investments	0.1	0.2	0.24
Total Debt	6.36	6.63	5.27
Net Cash (Debt)	-6.26	-6.43	-5.03
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Oct '22 Oct 31, 2022	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Operating Cash Flow	-0.33	-0.55	-1.65
Free Cash Flow	-0.33	-0.55	-1.65
Free Cash Flow Growth	-	-	-